UK markets closed

Enlivex Therapeutics Ltd. (ENLV)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.62000.0000 (0.00%)
At close: 04:00PM EDT
1.5500 -0.07 (-4.32%)
After hours: 04:27PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
Operating expenses
Research development
18,159
18,693
12,881
6,086
Selling general and administrative
7,440
6,702
6,240
3,602
Total operating expenses
25,766
25,797
19,288
9,785
Operating income or loss
-25,766
-25,797
-19,288
-9,785
Total other income/expenses net
-2,633
-6,084
5,028
-2,258
Income before tax
-28,607
-31,060
-14,468
-11,824
Income from continuing operations
-28,607
-31,060
-14,468
-11,824
Net income
-28,607
-31,060
-14,468
-11,824
Net income available to common shareholders
-28,607
-31,060
-14,468
-11,824
Basic EPS
-1.47
-1.69
-0.81
-0.90
Diluted EPS
-1.47
-1.69
-0.81
-0.90
Basic average shares
18,535
18,395
17,860
13,169
Diluted average shares
18,535
18,395
17,860
13,169